Michael Kann 法国波尔多大学——HBV相关实验室及人物介绍系列
简介HBV领域做入核机制的人不多，但是Michael Kann一直专注如该领域，先是在德国 Justus Liebig University，后到法国波尔多大学。正巧以前介绍过他一篇文章
http://bbs.virology.com.cn/viewthread.php?tid=15316，2010 plosone另一篇台湾施嘉和实验室文章比较彻底解决了C蛋白入核出核信号问题
实验室链接
http://www.mfp.cnrs.fr/mfp/team_dissv_en.php
http://mcmp.aquitaine.cnrs.fr/si ... nt1/kann_group.html
Research projects
Our group is working on the intracytoplasmic and the nuclear transport of different viral components that are involved in nuclear delivery of viral genomes. The main focus is the human hepatitis B virus as this virus exhibits an extreme efficiency. Being at the interphase between virology and cell biology our research targets the molecular interactions with cellular partners. The obtained data will result in a better understanding of basic cell biology and may help developing efficient vectors for gene therapy as well as identifying essential targets for antiviral therapy.
Introduction
For replication viruses have to transport their genome to the place where multiplication of the genomic information occurs. Viruses that make use of the nuclear replication processes and infect non-dividing cells have to deliver their genome through cytoplasm towards the nuclear envelope followed by entry into the karyoplasm by passing the nuclear pore complex (NPC) (for overview see figure 1). As nucleic acids are not karyophilic per se attached viral proteins have to mediate distinct and well coordinated interactions with the different cellular transport machineries. Evidently the location of the virus (or its subviral structure) has to be related with genome release in order to prevent premature abortion of the viral life cycle.
Hepatitis B virus
Amongst the depicted viruses human hepatitis B virus (HBV) is particular (figure 2). HBV is an enveloped pararetrovirus that multiplies via RNA synthesis. It enters the cell by a receptor(s) that have not been unequivocally identified yet. Independent upon acidification it releases the viral capsid into the cytoplasm. Subsequently the capsid surrounding the partially double stranded viral DNA is transported to the nucleus in which the genome becomes released. Cellular enzymes convert the viral genome to the covalently closed circular DNA (cccDNA) that is the template for mRNA synthesis. One mRNA of supergenomic length, the pregenomic RNA (PG) is bicistronic and encodes for the capsid protein and the viral polymerase (pol). Pol binds speci-fically to PG thereby facilitatin - ing encapsidation into the assembling capsid. Being only active in the capsid environment Pol converts the encapsidated RNA into the partially double stranded viral DNA. In contrast to all other viruses (exception: caulimoviruses of plants) the HBV capsids derived from cellular entry are identical to the mature progeny capsids. Hence not only incoming capsids but also the progeny ones are targeted to the nucleus (fig.1, red arrow) leading to amplification of the nuclear cccDNA. Only after sufficient amounts of surface proteins are synthesized the mature capsids become enveloped by the surface proteins leading to secretion of progeny HBV.
Our lab interests are focused on the intracytoplasmic and nuclear transport of the HBV by three reasons: (i) HBV is a major human pathogen causing one million deaths per year (ii) HBV is extremely efficient; practically all viruses represent an infectious unit. Learning the molecular interactions causing this performance can help to develop efficient vectors in gene therapy. (iii) The analysis of the cellular interaction partners will result in a better understanding of basic transport-related cell biology.
Intracytoplasmic transport. The main obstacle in HBV research is the lack of a commonly available cell line that is susceptible. Even primary human hepatocytes loose their susceptibility a few days after taken in culture. How ever after transfection of viral DNA hepatoma cell lines produce in vivo-likeamounts of virus indicating restrictions in viral entry. We there-fore replaced the viral envelope by lipids allowing the analysis of HBV travel towards the nucleus. Figure 3 depicts the time course of capsid transport and genome release. This system allowed determining the intracytoplasmic transport system and participating motor complexes. Detailed analysis shall identify the domains on capsid and motor proteins.
Nuclear transport. As depicted, the capsids release the genome exclusively into the nucleus implying a tight regulation of capsid disintegration. We analyzed the interactions at the nucleus in more detail using Digitonin-permeabilized cells. Digitonin permeabilizes the plasma membrane leaving the nuclear membrane integer.
We showed that the capsids interact with the NPC via the cellular nuclear import receptors importin a and ß. However RNA-containing capsids did not interact with the NPC (figure 4A), capsid with an immature DNA genome interact with the NPC without becoming imported (figure 4B) into the karyoplasm, while mature capsids containing the partially double stranded DNA caused nuclear capsid stain (figure 4C) and released genomes. Consistently only those capsids capable to interact with the nucleus exposed a nuclear localization signal (NLS) on their surface, while RNA-containing capsids hide the NLS in their interior. NLS are stretches of basic amino acids that interact with importin a. Nuclear transport mechanisms are phylogenetically well conserved. Consequently electron microscopy after microinjection of capsids into the cytoplasm of Xenopus laevis oocytes confirmed the interaction with the NPCs (Figure 5; collaboration with Nelly Panté, UBC, Canada). Further immature and mature capsids were depicted to enter the nuclear basket integer leading to a redefinition of the maximal nuclear pore size to be 39 nm (Panté & Kann, MBC, 2002). The basket is a cage-like structure on the karyoplasmic side of the NPC where cargo and import receptors dissociate, allowing that the cargo (in this case the capsid) diffuse deeper into the karyoplasm. So why do immature capsids arrest in the basket? And why do mature capsids enter the karyoplasm? Cross-linked mature capsids, unable to dissociate, behave like immature ones. They become arrested, implying that both capsid types interact with a protein of the nuclear basket. In collaboration with my lab at Giessen University, Germany, this protein could be identified to be nucleoporin 153 (Nup153), which is essential for cell viability.
Having these assays allows us (i) to evaluate Nup153 on import and export processes, (ii) to identify its function in capsid disassembly and (iii) evaluate the further fate of the genome.
HIV integrase and paroviruses
The studies are complemented by studying other viruses or subviral structures. In order to learn more about cargo-motor protein interactions we are currently evaluating the intracytoplasmic transport of the HIV integrase (HIV IN) in collaboration with Michel Fournier and Sébastien Desfarges in our department. HIV IN is not only of interest as it is an essential protein of the HIV preintegration complex but also as its small size allows a rapid identification of interaction domains.
Further nuclear interactions are investigated using parvoviruses. Like HBV capsids parvoviruses replicate in the nucleus, are small enough to pass the nuclear pore and contain a potential NLS hidden on one capsid protein. Nonetheless the nuclear entry of the parvoviral genome is controversial. Our analyses showed that despite of the potential NLS different parvoviruses cause local nuclear envelope break-down (NEBD). Physiologically NEBD occurs in mitosis, meiosis and apoptosis and our cell-free assays may help to unravel the signalling and nuclear degradation in these essential processes.
发表文章
1: Schmitz A, Schwarz A, Foss M, Zhou L, Rabe B, Hoellenriegel J, Stoeber M,
Panté N, Kann M. Nucleoporin 153 arrests the nuclear import of hepatitis B virus
capsids in the nuclear basket. PLoS Pathog. 2010 Jan 29;6(1):e1000741. PubMed
PMID: 20126445; PubMed Central PMCID: PMC2813275.
2: Rabe B, Delaleau M, Bischof A, Foss M, Sominskaya I, Pumpens P, Cazenave C,
Castroviejo M, Kann M. Nuclear entry of hepatitis B virus capsids involves
disintegration to protein dimers followed by nuclear reassociation to capsids.
PLoS Pathog. 2009 Aug;5(8):e1000563. Epub 2009 Aug 28. PubMed PMID: 19714236;
PubMed Central PMCID: PMC2727048.
3: Kantelhardt VC, Schwarz A, Wend U, Schüttler CG, Willems WR, Trimoulet P,
Fleury H, Gerlich WH, Kann M. Re-evaluation of anti-HBc non-reactive serum
samples from patients with persistent hepatitis B infection by immune
precipitation with labelled HBV core antigen. J Clin Virol. 2009 Oct;46(2):124-8.
Epub 2009 Jul 24. PubMed PMID: 19631583.
4: Rabe B, Glebe D, Kann M. Lipid-mediated introduction of hepatitis B virus
capsids into nonsusceptible cells allows highly efficient replication and
facilitates the study of early infection events. J Virol. 2006
Jun;80(11):5465-73. PubMed PMID: 16699026; PubMed Central PMCID: PMC1472160.
5: Rösler C, Köck J, Kann M, Malim MH, Blum HE, Baumert TF, von Weizsäcker F.
APOBEC-mediated interference with hepadnavirus production. Hepatology. 2005
Aug;42(2):301-9. PubMed PMID: 16025511.
6: Kann M. Interfering with capsid formation: a practicable antiviral strategy
against hepatitis B virus? Hepatology. 2004 Mar;39(3):838-40. PubMed PMID:
14999705.
7: Kann M. Nucleoprotein transport of HBV capsid particles. Methods Mol Med.
2004;95:213-26. PubMed PMID: 14762305.
bigbeb 发表于 2010-12-5 04:06
Michael Kann，波尔多，法国——HBV相关实验室及人物介绍系列
Michael Kann， CNRS, Bordeaux波尔多，法国
Blondot, M. L. and V. Bruss, et al. (2016). "Intracellular transport and egress of hepatitis B virus." J Hepatol 64(1 Suppl): S49-59.
Deroubaix, A. and Q. Osseman, et al. (2015). "Expression of viral polymerase and phosphorylation of core protein determine core and capsid localization of the human hepatitis B virus." J Gen Virol 96(Pt 1): 183-95.
Trimoulet, P. and P. Pinson, et al. (2013). "Dynamic and rapid changes in viral quasispecies by UDPS in chronic hepatitis C patients receiving telaprevir-based therapy." Antivir Ther 18(5): 723-7.
Schmitz, A. and A. Schwarz, et al. (2010). "Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket." PLoS Pathog 6(1): e1000741.
Wittkop, L. and A. Schwarz, et al. (2010). "Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation." Cell Microbiol 12(7): 962-75.
Kantelhardt, V. C. and A. Schwarz, et al. (2009). "Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen." J Clin Virol 46(2): 124-8.
Rabe, B. and M. Delaleau, et al. (2009). "Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids." PLoS Pathog 5(8): e1000563.
Kann, M. and A. Schmitz, et al. (2007). "Intracellular transport of hepatitis B virus." World J Gastroenterol 13(1): 39-47.
Rabe, B. and D. Glebe, et al. (2006). "Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events." J Virol 80(11): 5465-73.
Kann, M. (2004). "Interfering with capsid formation: a practicable antiviral strategy against hepatitis B virus?" Hepatology 39(3): 838-40.
Rabe, B. and A. Vlachou, et al. (2003). "Nuclear import of hepatitis B virus capsids and release of the viral genome." Proc Natl Acad Sci U S A 100(17): 9849-54.
Kock, J. and M. Kann, et al. (2003). "Central role of a serine phosphorylation site within duck hepatitis B virus coreprotein for capsid trafficking and genome release." J Biol Chem 278(30): 28123-9.
Kann, M. and B. Sodeik, et al. (1999). "Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex." J Cell Biol 145(1): 45-55.
Stoll-Becker, S. and R. Repp, et al. (1997). "Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients." J Virol 71(7): 5399-407.
Erhardt, A. and S. Schaefer, et al. (1996). "Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence." J Clin Microbiol 34(8): 1885-91.
Kann, M. and X. Lu, et al. (1995). "Recent studies on replication of hepatitis B virus." J Hepatol 22(1 Suppl): 9-13.
Kann, M. and W. H. Gerlich (1994). "Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus." J Virol 68(12): 7993-8000.
Kann, M. and H. G. Kochel, et al. (1993). "Diagnostic significance of antibodies to hepatitis B virus polymerase in acutelyand chronically HBV-infected individuals." J Med Virol 40(4): 285-90.
Kann, M. and R. Thomssen, et al. (1993). "Characterization of the endogenous protein kinase activity of the hepatitis B virus." Arch Virol Suppl 8: 53-62.
Kochel, H. G. and M. Kann, et al. (1991). "Identification of a binding site in the hepatitis B virus RNA pregenome for the viral Pol gene product." Virology 182(1): 94-101.
页:
[1]